Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Read the full articleYou might also wanna read
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Biogen's experimental Alzheimer's drug diranersen reduces tau tangles and shows modest cognitive benefit in clinical trial
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surpr
Science News·2d agoBiogen's experimental Alzheimer's drug diranersen reduces tau tangles and shows modest cognitive benefit in clinical trial
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surpr
sciencenews.org·2d agoBiogen's experimental Alzheimer's drug diranersen reduces tau tangles and shows modest cognitive benefit in clinical trial
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surpr
sciencenews.org·2d agoAn experimental Alzheimer’s drug shows promise targeting a different brain protein, new study shows
An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering The post An
An experimental Alzheimer’s drug shows promise targeting a different brain protein, new study shows
The company Biogen is planning a larger study to try to prove the drug’s benefit.
Comments
Sign in to join the conversation.
No comments yet. Be the first.